Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

@article{Barbara2009AminosalicylatesAO,
  title={Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome},
  author={Giovanni Barbara and Vincenzo Stanghellini and Cesare Cremon and Roberto De Giorgio and Lucia Fronzoni and Mauro Serra and Roberto Corinaldesi},
  journal={Digestive Diseases},
  year={2009},
  volume={27},
  pages={115 - 121}
}
  • Giovanni Barbara, Vincenzo Stanghellini, +4 authors Roberto Corinaldesi
  • Published 2009
  • Medicine
  • Digestive Diseases
  • Growing evidence suggests that gastrointestinal immune activation may affect intestinal function and sensory perception, which contribute to symptom generation in patients with irritable bowel syndrome (IBS). The identification of higher counts of immunocytes (e.g. T cells and mast cells), mucosal and systemic immune activation, and increased mucosal permeability in patients with IBS has stimulated interest in the potential development of therapeutic approaches aimed at targeting the immune… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 23 CITATIONS, ESTIMATED 59% COVERAGE

    The Immune System in Irritable Bowel Syndrome

    Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside

    VIEW 4 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.

    Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2009
    2017

    CITATION STATISTICS

    • 2 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 67 REFERENCES

    Increased mast cells in the irritable bowel syndrome.